NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Operating Leases (2019 - 2026)

NextPlat's (NXPL) quarterly Operating Leases came in at $576000.0 in Q2 2026, up 110.22% year-over-year from $274000.0 in Q2 2025, and down 10.14% quarter-over-quarter from $641000.0 in Q1 2026.

Analysis

NextPlat (NXPL) Operating Leases (2019 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Operating Leases for 8 consecutive years, with $576000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Operating Leases rose 110.22% year-over-year to $576000.0 in Q2 2026; TTM through Jun 2026 was $576000.0, a 110.22% increase from a year earlier, with the FY2025 full-year figure at $41000.0, down 90.64% from the prior year.
  • Operating Leases was $576000.0 for Q2 2026 at NextPlat, down from $641000.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $929000.0 in Q4 2023 and troughed at $41000.0 in Q4 2025.
  • A 5-year average of $574858.4 and a median of $607720.0 in 2023 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases soared 13326.63% in 2022 and plunged 90.64% in 2025, its largest moves.
  • Over 5 years, Operating Leases stood at $650000.0 in 2022, then jumped by 42.92% to $929000.0 in 2023, then slumped by 52.85% to $438000.0 in 2024, then sank by 90.64% to $41000.0 in 2025, then surged by 1304.88% to $576000.0 in 2026.
  • The last three Operating Leases figures came in at $576000.0 (Q2 2026), $641000.0 (Q1 2026), and $41000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 576,000.00
Mar 31, 2026 641,000.00
Dec 31, 2025 41,000.00
Sep 30, 2025 197,000.00
Jun 30, 2025 274,000.00
Mar 31, 2025 351,000.00
Dec 31, 2024 438,000.00
Sep 30, 2024 553,000.00
Jun 30, 2024 619,000.00
Mar 31, 2024 853,000.00
Dec 31, 2023 929,000.00
Sep 30, 2023 712,521.00
Jun 30, 2023 567,071.00
Mar 31, 2023 607,720.00
Dec 31, 2022 650,000.00
Sep 30, 2022 863,294.00
Jun 30, 2022 899,987.00
Dec 31, 2021 19,763.00
Jun 30, 2021 6,703.00
Mar 31, 2021 14,725.00